Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
I
116TH CONGRESS
1ST SESSION H. R. 5357
To amend the Public Health Service Act to authorize a pilot program to
develop, expand, and enhance the commercialization of biomedical prod-
ucts, and for other purposes.
IN THE HOUSE OF REPRESENTATIVES
DECEMBER 6, 2019
Mr. PETERS introduced the following bill; which was referred to the
Committee on Energy and Commerce
A BILL
To amend the Public Health Service Act to authorize a
pilot program to develop, expand, and enhance the com-
mercialization of biomedical products, and for other pur-
poses.
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled,
2
SECTION 1. SHORT TITLE.
3
This Act may be cited as the ‘‘Innovation Network
4
and Capital Act of 2019’’.
5
VerDate Sep 11 2014
04:11 Dec 12, 2019
Jkt 099200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H5357.IH
H5357
kjohnson on DSK79L0C42 with BILLS
2
•HR 5357 IH
SEC. 2. PILOT PROGRAM FOR RESEARCH STARTUPS.
1
Part A of title IV of the Public Health Service Act
2
(42 U.S.C. 281 et seq.) is amended by adding at the end
3
the following:
4
‘‘SEC. 404O. PILOT PROGRAM FOR RESEARCH STARTUPS.
5
‘‘(a) FUNDS.—The Director of NIH shall award
6
grants or contracts to eligible entities to develop, expand,
7
and enhance the commercialization of biomedical products.
8
‘‘(b) ELIGIBLE ENTITY.—In this section, the term
9
‘eligible entity’ means an entity receiving funding under—
10
‘‘(1) the Small Business Innovation Research
11
program of the National Institutes of Health; or
12
‘‘(2) the Small Business Technology Transfer
13
program of the National Institutes of Health.
14
‘‘(c) USE OF FUNDS.—An eligible entity shall use the
15
funds received through such grant or contract to sup-
16
port—
17
‘‘(1) the Commercialization Readiness Pilot
18
program of the National Institutes of Health;
19
‘‘(2) the Innovation Corps program of the Na-
20
tional Institutes of Health;
21
‘‘(3) the Commercialization Accelerator pro-
22
gram of the National Institutes of Health;
23
‘‘(4) the Commercialization Assistance program
24
of the National Institutes of Health; and
25
VerDate Sep 11 2014
01:43 Dec 14, 2019
Jkt 099200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H5357.IH
H5357
kjohnson on DSK79L0C42 with BILLS
3
•HR 5357 IH
‘‘(5) such other programs and activities as the
1
Director of NIH determines to be appropriate, to
2
support the commercialization stage of research,
3
later stage research and development, technology
4
transfer, and commercialization technical assistance.
5
‘‘(d) NIH STARTUP SUPPORT ACCOUNT.—
6
‘‘(1) ESTABLISHMENT.—There is established in
7
the Treasury an account, to be known as the NIH
8
Startup Support Account, for purposes of carrying
9
out this section.
10
‘‘(2) TRANSFER
OF
FUNDS.—There shall be
11
transferred to the NIH Startup Support Account
12
from
the
general
fund
of
the
Treasury,
13
$100,000,000 for each of fiscal years 2021 through
14
2025, to be available until expended without further
15
appropriation.’’.
16
Æ
VerDate Sep 11 2014
04:11 Dec 12, 2019
Jkt 099200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H5357.IH
H5357
kjohnson on DSK79L0C42 with BILLS